News

Preventive care declines from adolescence to young adulthood, with a subset of males remaining persistently disengaged from annual well visits.

Cumulative prenatal adversities were linked to higher adolescent mental health risk, highlighting the importance of prenatal history and early clinical monitoring.

A study found no increased risk of neuropsychiatric disorders in children after accounting for shared familial factors.

Data show that adolescents average more than 1 hour of smartphone use during school hours, raising concerns about attention, learning, and policy enforcement in schools.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

A study found that sodium supplementation did not significantly improve weight, length, or head circumference gains among infants.

Pertussis often presents as a prolonged cold, especially in infants. Early recognition, treatment, and vaccination are key to reducing severe disease and spread.

Starting HPV vaccination earlier improves access, builds trust with families, and increases uptake before virus exposure to prevent cancer.

A study found that more than two-thirds of adolescents with congenital heart disease experience at least one cardiac or noncardiac comorbidity.

New phase 3 trial data reveal fremanezumab's effectiveness and safety for preventing migraines in children, offering a vital treatment option.

Children hospitalized for bronchiolitis who received high-flow nasal cannula therapy were more likely to be diagnosed with asthma in early childhood.

The phase 3 SPACE trial showed fremanezumab reduced monthly migraine days vs placebo in pediatric patients with episodic migraine.

An acceptance and commitment therapy–based parenting program significantly reduced parental stress compared with usual care.

Phase 3 SCOUT-HCM results showed mavacamten significantly reduced LVOT gradient vs placebo in adolescents with obstructive HCM.

This recent FDA clearance expands the use of the iotaSOFT Insertion System for pediatric use.

Metformin safely lowered maternal glucose levels and cut the risk of neonatal hypoglycemia in pregnant patients receiving antenatal betamethasone.

A study found that nonmedically indicated formula supplementation among term infants is common and increasing over time.

Experts say recent CDC vaccine schedule changes may complicate clinician–family communication without altering the underlying evidence supporting pediatric vaccination.

New AAP guidance affirms mother’s own milk as optimal for very low birth weight infants, citing reduced NEC and infection risk and outlining donor milk use.

Young adult and adolescent survivors of childhood cancer exhibit accelerated epigenetic aging associated with worse neurocognitive outcomes.

The approval marks the first treatment for this neurodegenerative with a low survival rate beyond 3 years.

Katie McMahon and Kathy Baylis, PhD, discuss research showing that prenatal exposure to hot, humid conditions has significant effects on child growth and health.

Multiple adverse prenatal exposures have been linked to lasting behavioral problems and altered brain development through adolescence.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Maternal influenza and TDaP vaccination during pregnancy was associated with fewer influenza- and pertussis-related hospital and ED visits in infants younger than 6 months.

Mimi Lee, MD, PhD, noted that broader use of genomic testing could allow pediatric care to move beyond symptom-based diagnoses toward individualized treatment strategies.

The Phase 3 Beeline trial has begun dosing patients to evaluate radiprodil, a targeted NMDA receptor modulator designed to address the underlying biology of GRIN-related neurodevelopmental disorder.

Findings from a phase 2 trial showed that once-weekly TransCon CNP plus TransCon hGH produced durable growth and proportionality benefits in children with achondroplasia.